Authors: Bonner, JA Sloan, JA Rowland, KM Klee, GG Kugler, JW Mailliard, JA Wiesenfeld, M Krook, JE Maksymiuk, AW Shaw, EG Marks, RS Perez, EA

Citation: Ja. Bonner et al., Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer, CLIN CANC R, 6(2), 2000, pp. 597-601

Authors: Creagan, ET Suman, VJ Dalton, RJ Pitot, HC Long, HJ Veeder, MH Vukov, AM Rowland, KM Krook, JE Michalak, JC

Citation: Et. Creagan et al., Phase III clinical trial of the combination of cisplatin, dacarbazine, andcarmustine with or without tamoxifen in patients with advanced malignant melanoma, J CL ONCOL, 17(6), 1999, pp. 1884-1890

Authors: Loprinzi, CL Kugler, JW Sloan, JA Mailliard, JA Krook, JE Wilwerding, MB Rowland, KM Camoriano, JK Novotny, PJ Christensen, BJ

Citation: Cl. Loprinzi et al., Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia, J CL ONCOL, 17(10), 1999, pp. 3299-3306

Authors: Galanis, E Frytak, S Rowland, KM Sloan, JA Lennon, VA

Citation: E. Galanis et al., Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy, CANCER IMMU, 48(2-3), 1999, pp. 85-90

Authors: Martenson, JA Shanahan, TG O'Connell, MJ Cobau, CD Schroeder, G Burch, PA Levitt, R Rowland, KM

Citation: Ja. Martenson et al., Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy, CANCER, 86(4), 1999, pp. 710-714